AIRLINK 74.00 Decreased By ▼ -0.25 (-0.34%)
BOP 5.14 Increased By ▲ 0.09 (1.78%)
CNERGY 4.55 Increased By ▲ 0.13 (2.94%)
DFML 37.15 Increased By ▲ 1.31 (3.66%)
DGKC 89.90 Increased By ▲ 1.90 (2.16%)
FCCL 22.40 Increased By ▲ 0.20 (0.9%)
FFBL 33.03 Increased By ▲ 0.31 (0.95%)
FFL 9.75 Decreased By ▼ -0.04 (-0.41%)
GGL 10.75 Decreased By ▼ -0.05 (-0.46%)
HBL 115.50 Decreased By ▼ -0.40 (-0.35%)
HUBC 137.10 Increased By ▲ 1.26 (0.93%)
HUMNL 9.95 Increased By ▲ 0.11 (1.12%)
KEL 4.60 Decreased By ▼ -0.01 (-0.22%)
KOSM 4.83 Increased By ▲ 0.17 (3.65%)
MLCF 39.75 Decreased By ▼ -0.13 (-0.33%)
OGDC 138.20 Increased By ▲ 0.30 (0.22%)
PAEL 27.00 Increased By ▲ 0.57 (2.16%)
PIAA 24.24 Decreased By ▼ -2.04 (-7.76%)
PIBTL 6.74 Decreased By ▼ -0.02 (-0.3%)
PPL 123.62 Increased By ▲ 0.72 (0.59%)
PRL 27.40 Increased By ▲ 0.71 (2.66%)
PTC 13.90 Decreased By ▼ -0.10 (-0.71%)
SEARL 61.75 Increased By ▲ 3.05 (5.2%)
SNGP 70.15 Decreased By ▼ -0.25 (-0.36%)
SSGC 10.52 Increased By ▲ 0.16 (1.54%)
TELE 8.57 Increased By ▲ 0.01 (0.12%)
TPLP 11.10 Decreased By ▼ -0.28 (-2.46%)
TRG 64.02 Decreased By ▼ -0.21 (-0.33%)
UNITY 26.76 Increased By ▲ 0.71 (2.73%)
WTL 1.38 No Change ▼ 0.00 (0%)
BR100 7,874 Increased By 36.2 (0.46%)
BR30 25,599 Increased By 139.8 (0.55%)
KSE100 75,342 Increased By 411.7 (0.55%)
KSE30 24,214 Increased By 68.6 (0.28%)
Business & Finance

GSK Pakistan appoints Erum Shakir as new CEO

CEO of GSK Aziz ul Haq has reigned from his post citing family commitments. Erum has also served on the Board
Published February 20, 2020
  • CEO of GSK Aziz ul Haq has reigned from his post citing family commitments.
  • Erum has also served on the Board of Directors in GSK Pakistan and Bangladesh in her previous roles, informed the company.

 

Pharmaceutical giant, GlaxoSmithKline (GSK) Pakistan Limited has appointed Erum Shakir Rahim as new Chief Executive Officer (CEO) of the company, it was learnt on Thursday.  

“This is to inform the shareholders that Mr. Aziz Ul Haq Chief Executive Officer of GlaxoSmithKline Pakistan Limited has resigned to join his family in Australia. The Board of Directors has accepted his resignation with effect from March 01, 2020,” read a company’s’ notification issued at the Pakistan Stock Exchange (PSX).

The incoming CEO Erum Shakir Rahim is currently as General Manager, GSK Indonesia Pharma Emerging. The company said that Rahim “has a strong track record of success in multiple GM roles within GSK in Malaysia, Bangladesh and Indonesia.

The company informed that Erum contributed to “GSK Pakistan’s market leading position in the country with 12 percent market share and eight GSK brands in the top 20 by launching 20 new assets across several therapy areas as well as leading critical business development initiatives.”

Erum has also served on the Board of Directors in GSK Pakistan and Bangladesh in her previous roles, informed the company.

Comments

Comments are closed.